Bloomberg Intelligence

US Retail Earnings, Weight Loss Drug

Aug 23, 2024
Joining the discussion are Sam Fazeli, Director of Research at Bloomberg Intelligence, who shares insights from a study showing Eli Lilly's weight-loss drug significantly lowers diabetes risk. Mary Ross Gilbert analyzes Macy's and TJX earnings, revealing shifts in consumer habits. Jennifer Bartashus highlights Target's impressive sales recovery through strategic initiatives. They also touch on potential retail mergers impacting convenience stores, all while keeping an eye on the evolving retail landscape amidst economic pressures.
Ask episode
Chapters
Transcript
Episode notes